Literature DB >> 19562240

[PET-CT studies of metastasizing cancer of the colon and rectum. Variability of tumor aggressiveness as a micro-evolutionary process of cancer stem cells with predetermined prognosis].

F Stelzner1, D von Mallek, J Ruhlmann, H J Biersack.   

Abstract

Formation of cancer stem cells which are both rare and variably therapy-resistant marks the beginning of a new disease without precursors. Based on molecular changes, these cells are derived from normal cells and exhibit pre-programmed malignant behaviour. In vitro studies have shown that hybrid cancers which behave in a similar way to Dukes A, B or C cancers in vivo can be produce by horizontal gene transfer. The level of aggressiveness follows a Galton curve in the probability distribution. In the current paper we analyzed colorectal cancers by PET-CT in follow-up studies which extended over several years. We conclude that the primary tumors behave differently from distant metastases. Radical exstirpation of the primary tumor is able to cure the malignant process if the homing area is resected. The primary tumor acts as the supplier of cancer stem cells for metastases which appear in different organs. When chemotherapy is administered the distribution of metastases in different organs appears dependent of the response or non-response of cancer stem cells to this therapy. Large numbers of colorectal carcinomas existed for the same time duration before death (15 years) independent of the malignancy grade. The tumor metastasizes immediately after formation. The primary tumor and the metastases appear variably quickly depending on the malignancy grade and are autonomic processes.

Entities:  

Mesh:

Year:  2009        PMID: 19562240     DOI: 10.1007/s00104-009-1745-5

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  9 in total

Review 1.  Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance.

Authors:  Emina H Huang; David G Heidt; Chen-Wei Li; Diane M Simeone
Journal:  Surgery       Date:  2007-04       Impact factor: 3.982

2.  The Surgical Pathology of Rectal Cancer: President's Address.

Authors:  C E Dukes
Journal:  Proc R Soc Med       Date:  1944-02

3.  Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease.

Authors:  H Allgayer; M M Heiss; R Riesenberg; K U Grützner; A Tarabichi; R Babic; F W Schildberg
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

4.  [Autoregulatory growth control of adenomatous polyps and carcinogenesis in the colorectal region. Basics of tumor surgery Part I].

Authors:  F Stelzner
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

5.  ["Field cancerization"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].

Authors:  M Aivado; M Gynes; V Gorelov; W U Schmidt; H D Röher; P E Goretzki
Journal:  Chirurg       Date:  2000-10       Impact factor: 0.955

Review 6.  [PET studies of recurrent rectal carcinoma. Fundamental aspects of lymphatic metastasis of visceral and somatic carcinomas].

Authors:  F Stelzner; J Ruhlmann
Journal:  Chirurg       Date:  2001-05       Impact factor: 0.955

7.  [Colorectal cancer metastasis. Frequency, prognosis, and consequences].

Authors:  D Hölzel; R Eckel; J Engel
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

8.  Prognosis in relation to symptom duration in colon cancer.

Authors:  F T McDermott; E S Hughes; E Pihl; B J Milne; A B Price
Journal:  Br J Surg       Date:  1981-12       Impact factor: 6.939

9.  Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.

Authors:  G Riethmüller; E Schneider-Gädicke; G Schlimok; W Schmiegel; R Raab; K Höffken; R Gruber; H Pichlmaier; H Hirche; R Pichlmayr
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

  9 in total
  5 in total

1.  Ninety and still active in research.

Authors:  Hans Dieter Dahl; Gerald D Giebel
Journal:  Langenbecks Arch Surg       Date:  2012-02-17       Impact factor: 3.445

Review 2.  [Spontaneous change of malignancy of solid malignant tumors : statistical investigations of colorectal and pancreatic carcinoma].

Authors:  F Stelzner
Journal:  Chirurg       Date:  2012-08       Impact factor: 0.955

Review 3.  [Surgery without anatomy?].

Authors:  F Stelzner
Journal:  Chirurg       Date:  2016-08       Impact factor: 0.955

4.  [Prediction of prognosis of pancreatic cancer based on the homing area].

Authors:  F Stelzner; J Ruhlmann; D von Mallek
Journal:  Chirurg       Date:  2013-03       Impact factor: 0.955

5.  Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.

Authors:  Gundula Rendl; Lukas Rettenbacher; Johannes Holzmannhofer; Lidwina Datz; Cornelia Hauser-Kronberger; Gerd Fastner; Dietmar Öfner; Felix Sedlmayer; Christian Pirich
Journal:  Ann Nucl Med       Date:  2014-12-11       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.